Sean O'Reilly East Northport attending BIO-Europe conference in Germany

The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emergingBIO-Europe plays host to executives from:

• Established and emerging biotech companies
• Pharmaceutical companies
• Companies developing companion diagnostics
• Institutional financial firms
• Private investors including venture capital and private equity
• Industry related service companies

companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.

EBD Group invites biotech, midsize pharmaceutical, and next generation companies to submit an application for a company presentation at BIO-Europe^® 2011.

High level faculty on panels and workshops, in which industry experts provide updated analyses and share their experience with the audience.

A lively exhibition in the heart of the conference area showcasing services and technologies.

BIO-Europe 2010 Highlights

• 14,661 scheduled one-to-one meetings (+17% over 2009)
• 3,243 licensing opportunities were posted (+22% over 2009)
• 2,906 attendees (+16% over 2009)
• 1,688 companies (+21% over 2009)
• 170 company presentations
• 87 international exhibitors
• 48 countries
• 21 workshops and panel sessions

For more info:

http://www.seanoreillyeastnorthport.com